Pear Therapeutics Announces Market Authorization of reSET® from the Health Science Authority in Singapore for the Treatment of Adults with Substance Use Disorder
BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc. today announced that the Health Science Authority (HSA) of Singapore has authorized reSET® for the treatment of adults with substance use disorder (SUD) in that country. This is the first time the HSA has authorized a prescription digital therapeutic (PDT) with claims to treat disease and/or improve clinical…
Details